Potassium Chloride Tablet, E · 23 active FDA presentation rows for this drug
Brand: KLOR-CON
FDA lists Potassium Chloride Tablet, E as To Be Discontinued (Upsher-Smith Laboratories, LLC).
No availability text on this FDA row.
Potassium Chloride Tablet, Extended Release: To Be Discontinued
FDA availability text is not recorded on this row. 23 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Potassium Chloride Tablet, Extended Release
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Dosage Form
- Tablet
- Presentation
- Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-15)
- Package NDC
- 0245-5315-15
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jul 23, 2025
- Last Updated
- Jul 23, 2025
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug product
Full Drug Profile
potassium chloride
Side effects, interactions, warnings & more
Nearby, Other Potassium Shortage Records
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Upsher-Smith Laboratories, LLC
Tablet
Potassium Chloride Tablet, Extended Release
Upsher-Smith Laboratories, LLC
Tablet
FDA reason on file: Discontinuation of the manufacture of the drug product. General shortage guidance lives on the tracker hub.